The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseases

Published:2023-05 Issue: Volume:245 Page:108399
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Retnakumar Sruthi Vijaya,Chauvin Camille,Bayry Jagadeesh

Funder

H2020

Department of Biotechnology, Ministry of Science and Technology, India

Agence Nationale de la Recherche

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference127 articles.

1. Practical review of immunizations in adult patients with cancer;Ariza-Heredia;Human Vaccines & Immunotherapeutics,2015

2. AP-1 transcription factors as regulators of immune responses in Cancer;Atsaves;Cancers,2019

3. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2;Au;Nature Medicine,2021

4. Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection;Awadasseid;Biomedicine & Pharmacotherapy,2021

5. Restoring function in exhausted CD8 T cells during chronic viral infection;Barber;Nature,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paraneoplastic dermatomyositis and Stevens-Johnson syndrome related to immunotherapy;Immunotherapy;2024-06-18

2. N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1;Journal of Experimental & Clinical Cancer Research;2024-04-20

3. An On‐Demand Collaborative Innate–Adaptive Immune Response to Infection Treatment;Advanced Materials;2024-01-17

4. The role and mechanisms of PD-L1 in immune evasion during Talaromyces marneffei infection;International Immunopharmacology;2024-01

5. Blockade of PD‐1 and CTLA‐4: A potent immunotherapeutic approach for hepatocellular carcinoma;BioFactors;2023-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3